We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Cigna (CI) Gains As Market Dips: What You Should Know
Read MoreHide Full Article
In the latest trading session, Cigna (CI - Free Report) closed at $178.61, marking a +0.1% move from the previous day. This change outpaced the S&P 500's 0.81% loss on the day. Elsewhere, the Dow lost 0.56%, while the tech-heavy Nasdaq lost 1.27%.
Heading into today, shares of the health insurer had gained 3.1% over the past month, lagging the Finance sector's gain of 3.79% and the S&P 500's gain of 5.06% in that time.
CI will be looking to display strength as it nears its next earnings release. The company is expected to report EPS of $4.24, down 6.61% from the prior-year quarter. Our most recent consensus estimate is calling for quarterly revenue of $39.14 billion, up 9.22% from the year-ago period.
Looking at the full year, our Zacks Consensus Estimates suggest analysts are expecting earnings of $18.50 per share and revenue of $155.81 billion. These totals would mark changes of +8.5% and +11.16%, respectively, from last year.
Investors should also note any recent changes to analyst estimates for CI. These revisions help to show the ever-changing nature of near-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the company's business outlook.
Our research shows that these estimate changes are directly correlated with near-term stock prices. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection has moved 0.1% higher. CI is currently sporting a Zacks Rank of #3 (Hold).
Looking at its valuation, CI is holding a Forward P/E ratio of 9.64. This represents a no noticeable deviation compared to its industry's average Forward P/E of 9.64.
We can also see that CI currently has a PEG ratio of 0.87. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. The Insurance - Multi line industry currently had an average PEG ratio of 1.21 as of yesterday's close.
The Insurance - Multi line industry is part of the Finance sector. This industry currently has a Zacks Industry Rank of 175, which puts it in the bottom 32% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Cigna (CI) Gains As Market Dips: What You Should Know
In the latest trading session, Cigna (CI - Free Report) closed at $178.61, marking a +0.1% move from the previous day. This change outpaced the S&P 500's 0.81% loss on the day. Elsewhere, the Dow lost 0.56%, while the tech-heavy Nasdaq lost 1.27%.
Heading into today, shares of the health insurer had gained 3.1% over the past month, lagging the Finance sector's gain of 3.79% and the S&P 500's gain of 5.06% in that time.
CI will be looking to display strength as it nears its next earnings release. The company is expected to report EPS of $4.24, down 6.61% from the prior-year quarter. Our most recent consensus estimate is calling for quarterly revenue of $39.14 billion, up 9.22% from the year-ago period.
Looking at the full year, our Zacks Consensus Estimates suggest analysts are expecting earnings of $18.50 per share and revenue of $155.81 billion. These totals would mark changes of +8.5% and +11.16%, respectively, from last year.
Investors should also note any recent changes to analyst estimates for CI. These revisions help to show the ever-changing nature of near-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the company's business outlook.
Our research shows that these estimate changes are directly correlated with near-term stock prices. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection has moved 0.1% higher. CI is currently sporting a Zacks Rank of #3 (Hold).
Looking at its valuation, CI is holding a Forward P/E ratio of 9.64. This represents a no noticeable deviation compared to its industry's average Forward P/E of 9.64.
We can also see that CI currently has a PEG ratio of 0.87. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. The Insurance - Multi line industry currently had an average PEG ratio of 1.21 as of yesterday's close.
The Insurance - Multi line industry is part of the Finance sector. This industry currently has a Zacks Industry Rank of 175, which puts it in the bottom 32% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.